Enhanced pulmonary absorption of recombinant human insulin by pulmonary surfactant and phospholipid hexadecanol tyloxapol through Calu-3 monolayers

Pharmazie

Volumn 67, Issue 5, 2012, Pages 448-451

  Zheng, Jianheng ^a,b   Zheng, Yi ^b   Chen, Jiayin ^b   Fang, Fang ^b   He, Jiake ^b   Li, Ning ^b   Tang, Yue ^b   Zhu, Jiabi ^b   Chen, Xijing ^b  

^a SHANGHAI UNIVERSITY OF SPORT   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEXADECANOL; LUNG SURFACTANT; PHOSPHOLIPID HEXADECANOL TYLOXAPOL; RECOMBINANT HUMAN INSULIN; TYLOXAPOL; UNCLASSIFIED DRUG;

ARTICLE; CALU 3 CELL; CELL MEMBRANE PERMEABILITY; CELL TYPE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IN VIVO STUDY; MONOLAYER CULTURE; TIGHT JUNCTION; TRANSMISSION ELECTRON MICROSCOPY;

ABSORPTION; CELL LINE; CELL LINE, TUMOR; EPITHELIAL CELLS; FLUORESCENT DYES; HUMANS; INSULIN; L-LACTATE DEHYDROGENASE; LUNG; MICROSCOPY, ELECTRON, TRANSMISSION; PERMEABILITY; PHOSPHOLIPIDS; PULMONARY SURFACTANTS; RECOMBINANT PROTEINS; TETRAZOLIUM SALTS; THIAZOLES; TIGHT JUNCTIONS;

EID: 84862327411     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2012.1132     Document Type: Article

References (19)

1. Angelo R, Rousseau K, Grant M, Leone-Bay A, Richardson P (2009) Technosphere insulin: defining the role of Technosphere particles at the cellular level. J Diabetes Sci Technol 3: 545-554.
2. Beck-Broichsitter M, Ruppert C, Schmehl T, Guenther A, Betz T, Bakowsky U, Seeger W, Kissel T, Gessler T (2011) Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro. Nanomedicine 7: 341-350.
3. Chono S, Fukuchi R, Seki T, Morimoto K (2009) Aerosolized liposomes with dipalmitoyl phosphatidylcholine enhance pulmonary insulin delivery J Control Release 137: 104-109.
4. Cilek A, Celebi N, Tirnaksiz F, Tay A (2005) A lecithin-based microemulsion of rh-insulin with aprotinin for oral administration: Investigation of hypoglycemic effects in non-diabetic and STZ-induced diabetic rats. Int J Pharm 298: 176-185.
5. FukudaY, Tsuji T, Fujita T, Yamamoto A, Muranishi S (1995) Susceptibility of insulin to proteolysis in rat lung homogenate and its protection from proteolysis by various protease inhibitors. Biol Pharm Bull 18: 891-894.
6. Gao Y, He L, Katsumi H, Sakane T, Fujita T, Yamamoto A (2008) Improvement of intestinal absorption of insulin andwater-soluble macromolecular compounds by chitosan oligomers in rats. Int J Pharm 359: 70-78.
7. Grainger C, Greenwell L, Lockley D, Martin G, Forbes B (2006) Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier. Pharm Res 23: 1482-1490.
8. Hussain A, Arnold JJ, Khan MA, Ahsan F (2004) Absorption enhancers in pulmonary protein delivery. J Control Release 94: 15-24.
9. Ji Y, Liu C, Pei YY (2007) Artificial pulmonary surfactant as a carrier for intratracheally instilled insulin. Acta Pharmacol Sin 28: 744-750.
10. Martis PC, Whitsett JA, Xu Y, Perl A-KT, Wan H, Ikegami M (2006) C/EBPα is required for lung maturation at birth. Development 133: 1155-1164.
11. Matilainen L, Toropainen T, Vihola H, Hirvonen J, Järvinen T, Jarho P, Järvinen K (2008) In vitro toxicity and permeation of cyclodextrins in Calu-3 cells. J Control Release 126: 10-16.
12. Salem LB, Bosquillon C, Dailey LA, Delattre L, Martin GP, Evrard B, Forbes B (2009) Sparing methylation of [beta]-cyclodextrin mitigates cytotoxicity and permeability induction in respiratory epithelial cell layers in vitro. J Control Release 136: 110-116.
13. Seki T, Fukushi N, Chono S, Morimoto K (2008) Effects of sperminated polymers on the pulmonary absorption of insulin. J Control Release 125: 246-251.
14. Tormakangas L, Markkula E, Lounatmaa K, Puolakkainen M (2010) Chlamydia pneumoniae infection in polarized epithelial cell lines. Infect Immun 78: 2714-2722.
15. Wan H, Winton H, Soeller C, Stewart G, Thompson P, Gruenert D, Cannell M, Garrod D, Robinson C (2000) Tight junction properties of the immortalized human bronchial epithelial cell lines Calu-3 and 16HBE14o. Eur Respir J 15: 1058-1068.
16. Yamamoto A, Umemori S, Muranishi S (1994) Absorption enhancement of intrapulmonary administered insulin by various absorption enhancers and protease inhibitors in rats. J Pharm Pharmacol 46: 14-18.
17. Yamamoto A, Iseki T, Ochi-Sugiyama M, Okada N, Fujita T, Muranishi S (2001) Absorption of water-soluble compounds with different molecular weights and [Asu1.7]-eel calcitonin from various mucosal administration sites. J Control Release 76: 363-374.
18. Zhang Y, Zhu J, Tang Y, Chen X, Yang Y (2009) The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery. Drug Dev Ind Pharm 35: 1059-1065.
19. Zheng J, Zhang G, Lu Y, Fang F, He J, Li N, Talbi A, Zhang Y, Tang Y, Zhu J, Chen X (2010) Effect of pulmonary surfactant and phospholipid hexadecanol tyloxapol on recombinant human-insulin absorption from intratracheally administered dry powders in diabetic rats. Chem Pharm Bull 58: 1612-1616.